These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33929309)

  • 1. Lungs after COVID-19: Evolving Knowledge of Post-COVID-19 Interstitial Lung Disease.
    Aronson KI; Podolanczuk AJ
    Ann Am Thorac Soc; 2021 May; 18(5):773-774. PubMed ID: 33929309
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Corticosteroid in Persistent Post-COVID-19 Interstitial Lung Disease.
    Khaw CR; Richardson C; Bhowmik A; Agbetile J; Rajakulasingam RK
    Ann Am Thorac Soc; 2021 Sep; 18(9):1599. PubMed ID: 34191693
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-COVID Interstitial Lung Disease and Other Lung Sequelae.
    Barash M; Ramalingam V
    Clin Chest Med; 2023 Jun; 44(2):263-277. PubMed ID: 37085219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
    Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
    Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia.
    Kitayama T; Kitamura H; Hagiwara E; Higa K; Okabayashi H; Oda T; Baba T; Komatsu S; Iwasawa T; Ogura T
    Intern Med; 2020 Dec; 59(24):3207-3211. PubMed ID: 33087668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: Report of three cases demonstrating a good response to high-dose corticosteroid therapy.
    Uemasu K; Yasuda Y; Hirayama Y; Arasawa S; Iwashima D; Takahashi KI
    J Infect Chemother; 2022 Feb; 28(2):321-325. PubMed ID: 34810106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19 and autoimmune dysregulation: exploring common mechanisms and treatment strategies in interstitial lung disease].
    Zhang Z; Zhou M
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):571-575. PubMed ID: 38858210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients.
    Bellan M; Parisi S; Stobbione P; Pedrinelli AR; Rizzi E; Casciaro GF; Vassia V; Landi R; Cittone MG; Rigamonti C; Patrucco F; Ditto MC; Finucci A; Realmuto C; Todoerti M; Parodi M; Rossi P; Pirisi M; Fusaro E; Sainaghi PP
    Scand J Rheumatol; 2020 Nov; 49(6):505-506. PubMed ID: 32856492
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 as a causative agent of idiopathic interstitial pneumonia and interstitial pneumonia associated with collagen vascular disorders.
    Fujita J
    Respir Investig; 2020 Nov; 58(6):427-429. PubMed ID: 33032954
    [No Abstract]   [Full Text] [Related]  

  • 10. A Role for Steroids in COVID-19-associated Pneumonitis at Six-Week Follow-Up?
    Denneny EK; Garthwaite HS; Heightman MJ; Porter JC
    Ann Am Thorac Soc; 2021 Jun; 18(6):1082-1083. PubMed ID: 33735603
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic yield of point-of-care ultrasound imaging of the lung in patients with COVID-19.
    Gil-Rodrigo A; Llorens P; Martínez-Buendía C; Luque-Hernández MJ; Espinosa B; Ramos-Rincón JM
    Emergencias; 2020 Sep; 32(5):340-344. PubMed ID: 33006834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 pneumonia can cause irreversible lung damage in dermatomyositis with pre-existing interstitial lung disease.
    Hama S; Akiyama M; Shimada T; Higashida-Konishi M; Takei H; Izumi K; Oshima H; Okano Y
    Int J Rheum Dis; 2021 Sep; 24(9):1221-1223. PubMed ID: 34370393
    [No Abstract]   [Full Text] [Related]  

  • 13. [When COVID-19 encounters interstitial lung disease: challenges and management].
    Ren YH; Wang SY; Liu M; Guo YM; Dai HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Aug; 43(8):633-638. PubMed ID: 32198915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatomyositis-related interstitial lung disease mimicking COVID-19 pneumonia.
    Hayano S; Tokunaga K; Imamura Y; Oshikawa H
    Cleve Clin J Med; 2021 Sep; 88(9):484-486. PubMed ID: 34470751
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the use of corticosteroids for critically ill patients with SARS-CoV-2 interstitial pneumonia].
    Mingoia A; Lejeune F; Sottiaux T; Van Brussel C; Adam JF
    Rev Med Liege; 2020 Sup; 75(S1):133-137. PubMed ID: 33211436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of severe interstitial lung disease after COVID-19 vaccination.
    Kono A; Yoshioka R; Hawk P; Iwashina K; Inoue D; Suzuki M; Narita C; Haruta K; Miyake A; Yoshida H; Tosaka N
    QJM; 2022 Jan; 114(11):805-806. PubMed ID: 34618126
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-COVID Interstitial Lung Disease-The Tip of the Iceberg.
    Kewalramani N; Heenan KM; McKeegan D; Chaudhuri N
    Immunol Allergy Clin North Am; 2023 May; 43(2):389-410. PubMed ID: 37055095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home monitoring for patients with ILD and the COVID-19 pandemic.
    Nakshbandi G; Moor CC; Wijsenbeek MS
    Lancet Respir Med; 2020 Dec; 8(12):1172-1174. PubMed ID: 33075296
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient diaphragmatic thinning in patients with interstitial pneumonia due to SARS-CoV-2.
    Battisti S; Sanson G; Paolucci E; Giampalma E; Russo E; Bergamini C; Agnoletti V; Di Bella S; Palermo A; Scarlata S
    Int J Tuberc Lung Dis; 2022 Apr; 26(4):369-371. PubMed ID: 35351243
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-COVID Interstitial Lung Disease - The Looming Epidemic.
    Singh AK; Kumar OP; Bansal P; Margekar SL; Aggarwal R; Ghotekar LR; Gupta A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.